We are happy to announce that, as of 1st July 2014, the ESP has become part of the Fraunhofer Institute for Molecular Biology and Applied Ecology IME. View the current press releases for more information. We are currently working on an update of the webpage.
IME ScreeningPort (IME SP) is a research department which operates across four main business areas:
Drug Discovery – Working exclusively with academic and research institutes, IME SP provides a complete drug discovery research covering all stages from target validation via small molecule screening to candidate selection
Biomarker and Translational Research – In our specialist laboratory facilities embedded in a University clinical research centre, we support biomarker discovery studies for clinical and pre-clinical research projects
Enabling Technologies – The department actively develops and benchmarks novel assay and screening technologies in partnership with the life-science industry
R&D Information Technologies – IME SP provides expertise in life science oriented informatics areas including Computational Chemistry, Cheminformatics, Bioinformatics and scientific data preparation and analysis